CLOTTAFACT

LIVE

Serial Number

79348828

Owner

Laboratoire Français du Fractionnement et des Biotechnologies

Attorney

Luna Samman

Filing Date

Aug 11, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CLOTTAFACT Trademark

Serial Number: 79348828 • Registration: 7318153

CLOTTAFACT is a trademark filed by Laboratoire Français du Fractionnement et des Biotechnologies on August 11, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Laboratoire Français du Fractionnement et des Biotechnologies

3 avenue des Tropiques

Entity Type: 99

Legal Representation

Attorney of Record

Luna Samman

120 trademarks filed View all →

Correspondence Address

Luna Samman ArentFox Schiff LLP

1717 K Street, NW

Washington, DC 20006

UNITED STATES

Trademark Details

Filing Date

August 11, 2022

Registration Date

March 5, 2024

Published for Opposition

December 19, 2023

Goods & Services

Pharmaceutical products and preparations for the prevention, treatment and control of bleeding episodes; blood protein arrays of natural or transgenic, synthetic or semi-synthetic origin for medical diagnosis purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED

Sep 3, 2026 NREP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 6, 2024 FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 6, 2024 FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 6, 2024 FICR

NEW REPRESENTATIVE AT IB RECEIVED

May 7, 2024 NREP

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 5, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Mar 5, 2024 R.PR

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Feb 26, 2024 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 7, 2024 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Feb 7, 2024 OPNR

NOTIFICATION PROCESSED BY IB

Jan 2, 2024 GPNX

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 19, 2023 NPUB

PUBLISHED FOR OPPOSITION

Dec 19, 2023 PUBO

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Nov 29, 2023 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Nov 29, 2023 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 29, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 15, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 15, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 15, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 15, 2023 TROA

REFUSAL PROCESSED BY IB

Aug 6, 2023 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 9, 2023 RFCS

REFUSAL PROCESSED BY MPU

Jul 8, 2023 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 2, 2023 RFCR

NON-FINAL ACTION WRITTEN

Jun 1, 2023 CNRT

ASSIGNED TO EXAMINER

May 31, 2023 DOCK

APPLICATION FILING RECEIPT MAILED

Sep 6, 2022 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 2, 2022 NWOS

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Sep 1, 2022 SDRC

Related Trademarks

More from this Owner

7 CEVENFACTA

WILLFACT

More in Same Class

ESSENTIAL MULTIV DRINK

RS REVOLUTIONARY SUPPLEMENT, MY MIND, MY BODY, MY COMMUNITY

IMMUNE BOOST EXXTREME INGRAM FORMULATIONS HEART & ARTERIAL SUPPORT KIDNEY SUPPORT GUT HEALTH STRAWBERRY FLAVOR 15 SERVINGS (NET WT. 191 G) | DIETARY SUPPLEMENT

BEPSENTYZ

AN OUTSTANDING QUALITY

PUBLICLY PRIVATE